Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?

Cardiovascular diseases (CVD) are the leading cause of premature death and disability in humans that are closely related to lipid metabolism and signaling. This study aimed to assess whether circulating lysophospholipids (LPL), lysophosphatidic acids (LPA) and monoacylglycerols (MAG) may be consider...

Descripción completa

Detalles Bibliográficos
Autores principales: Duflot, Thomas, Tu, Ly, Leuillier, Matthieu, Messaoudi, Hind, Groussard, Déborah, Feugray, Guillaume, Azhar, Saïda, Thuillet, Raphaël, Bauer, Fabrice, Humbert, Marc, Richard, Vincent, Guignabert, Christophe, Bellien, Jérémy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621392/
https://www.ncbi.nlm.nih.gov/pubmed/34822442
http://dx.doi.org/10.3390/metabo11110784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621392/
https://www.ncbi.nlm.nih.gov/pubmed/34822442
http://dx.doi.org/10.3390/metabo11110784

Ejemplares similares